Opinion

Dec 27, 2024, 14:51

Milind Javle: Radiofrequency Ablation VS Stereotactic Body Radiotherapy for Recurrent Small HCC

Milind Javle, Professor of GI Oncology at MD Anderson Cancer Center, shared a post on X:

“Radiofrequency Ablation Versus Stereotactic Body Radiotherapy for Recurrent Small Hepatocellular Carcinoma. SBRT superior local control/ PFS for small recurrent HCC.”

Radiofrequency Ablation Versus Stereotactic Body Radiotherapy for Recurrent Small Hepatocellular Carcinoma: A Randomized, Open-Label, Controlled Trial | Journal of Clinical Oncology (JCO)

Authors: Mian Xi et al.

Thor Halfdanarson , Professor of Oncology at Mayo Clinic, shared this post on X, adding:

“And this is why we do randomized, controlled trials, my friends… You work with the data you have at the time until you get better quality data.

I like being proven wrong, especially if based on solid data (see below)…”

Radiofrequency Ablation Versus Stereotactic Body Radiotherapy for Localized Hepatocellular Carcinoma in Nonsurgically Managed Patients: Analysis of the National Cancer Database

Authors: Devalkumar J. Rajyaguru et al.

Milind Javle: Radiofrequency Ablation VS Stereotactic Body Radiotherapy for Recurrent Small HCC

A. Nicholas Kurup Alping Fang Andrew J. Borgert Angela L. Smith Baoqing Chen cancer Dandan Hu Devalkumar J. Rajyaguru Jing Zhao Jingxian Shen Li Hu Li Xu Mark J. Truty Mengzhong Liu Mian Xi Minshan Chen OncoDaily Oncology Patrick D. Conway Qiaoqiao Li Reggie M. Thomes Ronald S. Go Thorvardur R. Halfdanarson Yizhen Fu Zhongguo Zhou

Oncologist Near Me - Matti Aapro: Pioneering Excellence in Cancer Care and Geriatric Oncology

World Cancer Day: 25 Years of Global Action and Unity in the Fight Against Cancer

Oncologist Near Me – Giuseppe Curigliano: A Prominent Specialist in Breast Cancer Clinical Trials and Research

FDA Approves T-DXd for HR+, HER2-Low/Ultralow Breast Cancer Treatment

Oncologist Near Me - Hagop Kantarjian: A Legend in Leukemia Research and Treatment